ADVERTISEMENT

RVL Prescription drugs (RVLP) This autumn 2022 Earnings Name Transcript

74
SHARES
1.2k
VIEWS
ADVERTISEMENT
ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

ADVERTISEMENT


RVL Prescription drugs plc (NASDAQ:RVLP) This autumn 2022 Earnings Convention Name March 20, 2023 8:30 AM ET

Firm Individuals

Brian Markison – Chief Govt Officer

JD Schaub – Chief Working Officer

Mike DePetris – Chief Monetary Officer (interim)

Lisa Wilson – In-Website Communications

Convention Name Individuals

Louise Chen – Cantor Fitzgerald

Douglas Tsao – HC Wainwright

Greg Fraser – Truist Securities

John Vandermosten – Zack’s

Unknown Analyst – Barclays

Glen Santangelo – Jefferies

Operator

Good morning everybody. My title is Shelby and I will likely be your convention Operator.

Right now, I’d prefer to welcome everybody to the RVL Prescription drugs fourth quarter and full yr 2022 monetary outcomes name.

All traces have been positioned on mute to stop any background noise. After the audio system’ remarks, there will likely be a query and reply interval. At the moment, you probably have a query, please press star and one in your phone keypad. As a reminder, this convention name is being recorded right this moment, March 20, 2023.

It’s now my pleasure to show the ground over to Ms. Lisa Wilson, Investor Relations for RVL Prescription drugs. Please go forward.

Lisa Wilson

Thanks Operator. Welcome to RVL Prescription drugs fourth quarter 2022 monetary outcomes and industrial replace name. That is Lisa Wilson, Investor Relations for RVL. With me on right this moment’s name are RVL’s Chief Govt Officer, Brian Markison, Chief Working Officer, JD Schaub, and interim Chief Monetary Officer, Mike DePetris.

This morning, the corporate issued a press launch detailing monetary outcomes for the three months ended December 31, 2022. This press launch and a webcast of this name could be accessed by way of the Buyers part of the RVL web site at rvlpharma.com.

Earlier than we get began, I wish to remind everybody that any statements made on right this moment’s convention name that categorical a perception, expectation, projection, forecast, anticipation or intent relating to future occasions

Gaze week

Gaze week

it is world news site that provides up-to-date news and information about world